JP MORGAN/CALL/MEDTRONIC/105/0.1/16.01.26 Share Price

Warrant

DE000JT3EMR2

Market Closed - Börse Stuttgart 10:21:30 05/07/2024 BST
0.21 EUR 0.00% Intraday chart for JP MORGAN/CALL/MEDTRONIC/105/0.1/16.01.26
Current month-16.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/07/24 0.21 0.00%
04/07/24 0.21 -4.55%
03/07/24 0.22 +10.00%
02/07/24 0.2 -20.00%
01/07/24 0.25 0.00%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 10:21 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer J.P. Morgan
WKN JT3EMR
ISINDE000JT3EMR2
Date issued 12/06/2024
Strike 105 $
Maturity 16/01/2026 (558 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.32
Lowest since issue 0.2
Delta0.21x
Omega 6.593
Premium38.5x
Gearing31.13x
Moneyness 0.7391
Difference Strike 27.39 $
Difference Strike %+26.09%
Spread 0.04
Spread %16.00%
Theoretical value 0.2300
Implied Volatility 24.43 %
Total Loss Probability 85.73 %
Intrinsic value 0.000000
Present value 0.2300
Break even 107.49 €
Theta-0x
Vega0.03x
Rho0.02x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.61 USD
Average target price
94.02 USD
Spread / Average Target
+21.15%
Consensus